Default company panoramic image
Logo

Biorasis Inc

BIORASIS has developed a biosensor aimed to revolutionize the way by which pre-clinical animal research is conducted for drug-development

  • Stage Concept Only
  • Industry Not Set
  • Location Mansfield, CT, USA
  • Currency USD
  • Website bio-orasis.com

Company Summary

Biorasis is working towards the development of a miniaturized implantable continuous glucose sensor (CGM) for use in the pre-clinical animal research market. Due to its miniaturized size it is the only CGM that can be used in rodents, which are 98% of the animals used in research for drug-development. The savings from using our sensor as opposed to other technologies, is ca. 84% cost reduction for a 1 month research study.

Team

  • Default avatar
    Ioannis Tomazos
    Chief Executive Officer

    Ioannis Tomazos, Ph.D., M.B.A. Since being appointed as the CEO of Biorasis Inc in 2008, Dr. Tomazos and his company have received numerous awards including the "Most Promising Life Sciences Company" in 2011 from the Connecticut Technology Council. He has served as the Principal Investigator for NIH and NSF SBIR grants, in addition to being a frequent panelist and
    speaker in a number of meetings. He is currently working with his
    company toward

  • Default avatar
    Fotios Papadimitrakopoulos
    Vice President and Chairman of the Board

    Currently serving as Professor of Chemistry and Associate Director of the Institute of Materials Science at University of Connecticut, has over 15 years of experience in the areas of nano/bio-systems, supramolecular assembly of man-made artificial nanostructures and their unique interactions with biological entities (such as proteins, DNA and biocompatible polymers). Dr. Papadimitrakopoulos is a member of the Connecticut Academy of Science & Engi

  • Default avatar
    Faquir Jain
    Vice President

    Currently serving as Professor of Electrical & Computer Engineering at the University of Connecticut, has over 35 years of experience in the areas design and fabrication of micro/opto-electronic devices and integrated circuits, multiple quantum-well light valves/modulators, acoustic-optic/electro-optic modulators, semiconductor lasers, opto-electronically triggered lasers, modeling, and transport in quantum wires and dots. Dr. Jain serves as the

  • Default avatar
    Ioannis Tomazos
    Chief Executive Officer

    Ioannis Tomazos, Ph.D., M.B.A. Since being appointed as the CEO of Biorasis Inc in 2008, Dr. Tomazos and his company have received numerous awards including the "Most Promising Life Sciences Company" in 2011 from the Connecticut Technology Council. He has served as the Principal Investigator for NIH and NSF SBIR grants, in addition to being a frequent panelist and
    speaker in a number of meetings. He is currently working with his
    company toward

  • Default avatar
    Fotios Papadimitrakopoulos
    Vice President & Chairman

    Currently serving as Professor of Chemistry and Associate Director of the Institute of Materials Science at University of Connecticut, has over 15 years of experience in the areas of nano/bio-systems, supramolecular assembly of man-made artificial nanostructures and their unique interactions with biological entities (such as proteins, DNA and biocompatible polymers). Dr. Papadimitrakopoulos is a member of the Connecticut Academy of Science & Engi

  • Default avatar
    Faquir Jain
    Vice President

    Currently serving as Professor of Electrical & Computer Engineering at the University of Connecticut, has over 35 years of experience in the areas design and fabrication of micro/opto-electronic devices and integrated circuits, multiple quantum-well light valves/modulators, acoustic-optic/electro-optic modulators, semiconductor lasers, opto-electronically triggered lasers, modeling, and transport in quantum wires and dots. Dr. Jain serves as the